Want to see GENB full AI Analyst Report?

Generate Biomedicines, Inc. (GENB) Cash flow

149 Followers

Generate Biomedicines, Inc. Cash Flow

GENB's free cash flow for Q2 2026 was $-58.88M. For the 2026 fiscal year, GENB's free cash flow was decreased by $-82.94M and operating cash flow was $-57.94M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24
Operating Cash Flow	$ -200.62M	$ -117.75M
Investing Cash Flow	$ 116.77M	$ -57.73M
Financing Cash Flow	$ 28.06M	$ 91.33M
End Cash Position	$ 126.04M	$ 181.83M
Free Cash Flow	$ -204.13M	$ -121.20M

Currency in USD